- Home
- IMNM vs WB Comparison
IMNM vs WB Comparison
Compare IMNM & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMNM | WB |
|---|---|---|
| Founded | 2006 | 2009 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.5B |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | IMNM | WB |
|---|---|---|
| Price | $22.66 | $10.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $31.22 | $14.00 |
| AVG Volume (30 Days) | ★ 2.5M | 1.0M |
| Earning Date | 11-06-2025 | 11-18-2025 |
| Dividend Yield | N/A | ★ 15.26% |
| EPS Growth | N/A | ★ 20.16 |
| EPS | N/A | ★ 1.76 |
| Revenue | $9,679,000.00 | ★ $1,740,785,000.00 |
| Revenue This Year | N/A | $0.53 |
| Revenue Next Year | $11.53 | $2.38 |
| P/E Ratio | ★ N/A | $6.12 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.15 | $7.10 |
| 52 Week High | $25.30 | $12.96 |
Technical Indicators
Market Signals| Indicator | IMNM | WB |
|---|---|---|
| Relative Strength Index (RSI) | 60.67 | 54.37 |
| Support Level | $20.05 | $10.46 |
| Resistance Level | $22.01 | $11.22 |
| Average True Range (ATR) | 1.28 | 0.25 |
| MACD | 0.04 | 0.05 |
| Stochastic Oscillator | 82.00 | 58.59 |
Price Performance
Historical ComparisonAbout IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About WB Weibo Corporation
Weibo Corp is a China-based company mainly engaged in the social media advertising business for people to create, discover and distribute content. The company's activities include Advertising and Marketing, which mainly provides a full range of advertising customization and marketing solutions. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The Company's main product is the social platform Weibo.